Skip to main content
Michael Leapman, MD, Urology, New Haven, CT

MichaelStuartLeapmanMD

Urology • New Haven, CT

Surgical Oncology

Physician

Join to view full profile

Dr. Leapman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Leapman's full profile

Already have an account?

  • Office

    800 Howard Avenue
    Yale Physicians Building
    New Haven, CT 06519

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Minimally Invasive Urologic Surgery, 2014 - 2016
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Urology, 2010 - 2014
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 2009 - 2010
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2009

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2016 - 2025
  • NY State Medical License
    NY State Medical License 2011 - 2015
  • American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer  
    Michael Leapman, MD, JAMA Oncology

Lectures

  • Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Is This the Best Screening Test for Prostate Cancer?
    Is This the Best Screening Test for Prostate Cancer?September 11th, 2023
  • More Selective Prostate Biopsy Approaches Could Greatly Reduce Health Care Pollution
    More Selective Prostate Biopsy Approaches Could Greatly Reduce Health Care PollutionMay 23rd, 2023
  • Findings from Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier
    Findings from Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility of Veracyte's Decipher Prostate Genomic ClassifierApril 29th, 2023
  • Join now to see all

Dr. Michael Leapman, Dr. Michael Leapman, MD, Dr. M Leapman, Dr. Michael Stuart Leapman